未登录

H

Hibah M. Aldawsari

King Abdulaziz University

H指数:34

被引数:3,707

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Okra polysaccharides: A promising natural polymer for advanced drug delivery systems

秋葵多糖：一种用于先进药物递送系统的有前景天然聚合物

Journal of Drug Delivery Science and Technology

IF4.9

2026-04-250

PRE

Validation, quantification, and molecular docking of isolated eupalitin 3-O-β-D-galactopyranoside in Boerhavia diffusa Linn for hepatoprotective and immunomodulatory activity

验证、定量及分子对接：从 Boerhavia diffusa Linn 中分离的 eupalitin 3-O-β-D-galactopyranoside 的保肝和免疫调节活性研究

Scientific Reports

IF3.9

2026-03-300

OAAI

Solvent-free green preparation of niacinamide niosomes for targeting UVB-induced hyperpigmentation: QbD-based optimisation and in vivo assessment

用于靶向UVB诱导的色素沉着过度的烟酰胺类药物的无溶剂绿色制备: 基于QbD的优化和体内评估

Journal of Drug Targeting

IF3.9

2026-02-050

PRE

Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa

IF3.7

2025-02-220

OAAI

Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide against Lung Cancer Cells. Pharmaceutics (vol 14, 227, 2022)

IF5.5

2025-01-140

OAAI

RETRACTION: Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery.

IF5.5

2024-05-270

OAAI

RETRACTION: Gum Acacia Functionalized Colloidal Gold Nanoparticles of Letrozole as Biocompatible Drug Delivery Carrier for Treatment of Breast Cancer

IF5.5

2024-05-270

OAAI

Utilization of zein nano-based system for promoting antibiofilm and anti-virulence activities of curcumin against Pseudomonas aeruginosa

NANOTECHNOLOGY REVIEWS

IF6.1

2024-03-117

OA

Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome(vol26, 866, 2021)

IF4.6

2024-02-190

OAAI

RETRACTION: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment. (Retraction of Vol 13, art no 783, 2021)

IF5.5

2024-01-300

OAAI

RETRACTION: Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells (Retraction of Vol 12, art no 346, 2020)

IF5.5

2024-01-300

OAAI

RETRACTION: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation (Retraction of Vol 12, art no 485, 2020)

IF5.5

2024-01-290

OAAI

RETRACTION: Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans (Retraction of Vol 13, art no 977, 2021)

IF5.5

2024-01-220

OAAI

RETRACTION: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route (Retraction of Vol 10, art no 1270, 2020)

IF4.3

2024-01-120

OAAI

RETRACTION: Fluvastatin-Loaded Emulsomes Exhibit Improved Cytotoxic and Apoptosis in Prostate Cancer Cells (Retraction of Vol 22, Pg 177, 2021)

AAPS PHARMSCITECH

IF4

2023-06-020

OA

Colon Targeted Eudragit Coated Beads Loaded with Optimized Fluvastatin-Scorpion Venom Conjugate as a Potential Approach for Colon Cancer Therapy: In Vitro Anticancer Activity and In Vivo Colon Imaging

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2022-12-014

PRE

RETRACTED: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer (Retracted Article)

SCIENTIFIC REPORTS

IF3.9

2022-11-147

OA

Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment

IF8.1

2022-08-1611

OAAI

Progress in Polymeric Micelles for Drug Delivery Applications

IF5.5

2022-08-05108

OAAI

Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects

PHARMACEUTICALS

IF4.8

2022-07-2743

OAAI